Generic Clozapine: A Cost-Saving Alternative to Brand Name Clozapine?

Author： Tse G.  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.21, Iss.1, 2003-01, pp. : 1-11

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

What is an Adequate Trial with Clozapine?: Therapeutic Drug Monitoring and Time to Response in Treatment-Refractory Schizophrenia

By Schulte Peter F.J.  

Clinical Pharmacokinetics, Vol. 42, Iss. 7, 2003-01 ,pp. : 607-618

Adis International

Access to resources Recommend Favorite

When Should Clozapine Be Initiated in Schizophrenia?: Some Arguments For and Against Earlier Use of Clozapine

By Kerwin Robert  

CNS Drugs, Vol. 21, Iss. 4, 2007-01 ,pp. : 267-278

Adis International

Access to resources Recommend Favorite

A Bioequivalence Study of Brand and Generic Clozapine in Patients with Schizophrenia: Pharmacokinetic and Tolerability Findings

By Sramek J.J.  

Clinical Drug Investigation, Vol. 17, Iss. 1, 1999-01 ,pp. : 51-58

Adis International

Access to resources Recommend Favorite

The Generic Alternative in Schizophrenia: Opportunity or Threat?

By Philippe Nuss  

CNS Drugs, Vol. 18, Iss. 12, 2004-01 ,pp. : 769-775

Adis International

Access to resources Recommend Favorite

Remifentanil cost saving vs fentanyl in CABG surgery?

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 388, 2002-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite